The aim of this study was to compare the accuracy of MRI for prediction of
response to Neo-adjuvant chemotherapy in Triple negative (TN) breast cancer,
with respect to other molecular types.
There
were a total of 1610 breast cancers diagnosed between March 2009 and August
2014, out of which 82 patients underwent MRI before and after neo-adjuvant
chemotherapy but just before surgery.
Triple negative
cancers were analysed with respect to others subtypes. Accuracy of MRI for
prediction of pathological complete response was compared between different subtypes,
by obtaining ROC curves.
No comments:
Post a Comment